...
首页> 外文期刊>Digestive Diseases and Sciences >Shared Genetic Risk Factors in Autoimmune Liver Disease
【24h】

Shared Genetic Risk Factors in Autoimmune Liver Disease

机译:自身免疫性肝病的共同遗传风险因素

获取原文
获取原文并翻译 | 示例
           

摘要

To determine if shared genetic risk factors for autoimmune liver disease affect clinical manifestations, we evaluated 271 patients and 92 normal subjects by DNA-based techniques. Genetic risk factors were intermixed in all conditions, and frequency varied according to disease type. DR4 distinguished autoimmune hepatitis (P = 0.0002) and primary biliary cirrhosis (P = 0.004) from primary sclerosing cholangitis. DR52 distinguished primary sclerosing cholangitis from autoimmune hepatitis (P = 0.0007) and primary biliary cirrhosis (P = 0.00007) and DR3 distinguished autoimmune hepatitis (P = 0.002) and primary sclerosing cholangitis (P = 0.0005) from primary biliary cirrhosis. Only the occurrence of DR4 in primary sclerosing cholangitis was lower than in normal subjects (P = 0.02). Patients with mixed genetic risk factors did not have distinctive features or manifestations of hybrid conditions. We conclude that patients with shared genetic risk factors do not have characteristic features nor do they have overlap syndromes. DR4 may be protective against primary sclerosing cholangitis.
机译:为了确定自身免疫性肝病的共同遗传危险因素是否影响临床表现,我们通过基于DNA的技术评估了271例患者和92例正常受试者。遗传危险因素在所有情况下都混杂在一起,频率根据疾病类型而变化。 DR4将原发性硬化性胆管炎与自身免疫性肝炎(P = 0.0002)和原发性胆汁性肝硬化(P = 0.004)区别开来。 DR52将原发性硬化性胆管炎与自身免疫性肝炎(P = 0.0007)和原发性胆汁性肝硬化(P = 0.00007)区别开来,DR3将原发性免疫性肝炎(P = 0.002)和原发性胆汁性胆管炎(P = 0.0005)与原发性胆汁性肝硬化区别开来。仅DR4在原发性硬化性胆管炎中的发生率低于正常人(P = 0.02)。具有混合遗传危险因素的患者没有混合疾病的明显特征或表现。我们得出的结论是,具有共同的遗传危险因素的患者没有特征,也没有重叠综合征。 DR4可以预防原发性硬化性胆管炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号